Laborate Pharmaceuticals India Ltd - Company Profile

It is a pharma public limited company based in Haryana, Haryana, India, established in 1990.
1990 Haryana, Haryana, India Active
Last Updated:
About Laborate Pharmaceuticals India Ltd

Laborate Pharmaceuticals India Ltd, a active public limited company, was established on 01 March 1990 in Haryana, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239HR1990PLC030835. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.63 Cr.

Formerly known as Laborate Pharmaceuticals India Pvt Ltd. It upholds a compliant status. Employing 1,527 professional, Its leadership includes Arpit Bhatia (Whole-Time Director), Sanjay Bhatia (Whole-Time Director), Ajay Bhatia (Whole-Time Director). Past directors included Sanjay Bhatia, Ajay Bhatia, Aditya Bhatia. It holds ₹183.50 Cr open charges and ₹72.19 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at E-11 Industrial Areapanipat, Haryana, Haryana, 132103.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239HR1990PLC030835

  • Registration Number

    030835

  • Incorporation Date

    01 March 1990

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹2.63 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 2.63 Cr
  • Company Age 35 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 183.50 Cr
  • Satisfied Charges ₹ 72.19 Cr
  • Revenue Growth **** 17.56%
  • Profit Growth **** 8.54%
  • Ebitda **** 11.82%
  • Net Worth 15.27%
  • Total Assets **** 4.02%
Company report

Laborate Pharmaceuticals India Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Laborate Pharmaceuticals India Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Laborate Pharmaceuticals India Ltd?
Current Directors
Name Designation Appointment Date Status
Arpit Bhatia Whole-Time Director 01 Aug 2021 Current
Sanjay Bhatia Whole-Time Director 16 Apr 1990 Current
Ajay Bhatia Whole-Time Director 16 Apr 1990 Current
Garima Parashar Director 22 Jul 2021 Current
Parag Bhatia Whole-Time Director 28 Jun 2014 Current
Sidharth Verma Director 01 Oct 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2008 Past
Pramod Abcsdd Director 01 Apr 2008 Past
Pramod Abcsdd Director 01 Apr 2008 Past
Pramod Abcsdd Director 21 Mar 2024 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 28 Feb 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Laborate Pharmaceuticals India.

Laborate Pharmaceuticals India Ltd, for the financial year ended 2025, experienced significant growth in revenue, with a 17.56% increase. The company also saw a slight improvement in profitability, with a 8.54% increase in profit. The company's net worth Soared by an impressive increase of 15.27%.

Laborate Pharmaceuticals India revenue growth over time
Laborate Pharmaceuticals India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
17.56%
*******
*******
*******
*******
Revenue from Operations
*******
17.56%
*******
*******
*******
*******
Total Assets
*******
4.02%
*******
*******
*******
*******
Profit or Loss
*******
8.54%
*******
*******
*******
*******
Net Worth
*******
15.27%
*******
*******
*******
*******
EBITDA
*******
11.82%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Laborate Pharmaceuticals India?

In 2024, Laborate Pharmaceuticals India had a promoter holding of 71.62% and a public holding of 28.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,835,000,000.00

Satisfied Charges

₹721,851,000.00

Charges Breakdown by Lending Institutions
  • Others : 182.00 Cr
  • Axis Bank Limited : 1.50 Cr
Latest Charge Details
Date Lender Amount Status
17 Sep 2025 Axis Bank Limited ₹1.50 Cr Open
23 Jun 2005 Others ₹182.00 Cr Open
17 Jan 2024 Axis Bank Limited ₹1.00 Cr Satisfied
27 Jun 2018 Others ₹7.50 Cr Satisfied
31 Aug 2015 Punjab National Bank ₹4.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Laborate Pharmaceuticals India?

Laborate Pharmaceuticals India has a workforce of 1527 employees as of Jan 14, 2026. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Laborate Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laborate Pharmaceuticals India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Laborate Pharmaceuticals India
Recent Activity within the Organization
  • Annual General Meeting

    Laborate Pharmaceuticals India Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 1.50 Cr with Charge ID 101186139 was registered on 17 Sep 2025. was completed.

  • Charges

    The activity A charge registered on 17 Jan 2024 via Charge ID 100863584 with Axis Bank Limited was fully satisfied on 07 Jul 2025. was completed.

  • Director Appointment

    The activity Sanjay Kundu was appointed as a Director was appointed as a Director on 22 May 2025 & has been associated with this company since 9 months 1 day . was completed.

  • Balance Sheet

    Laborate Pharmaceuticals India Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100863584 was registered on 17 Jan 2024. was documented.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Laborate Pharmaceuticals India Ltd?

The CIN of Laborate Pharmaceuticals India Ltd is U24239HR1990PLC030835.

Where is Laborate Pharmaceuticals India Ltd headquartered?

Laborate Pharmaceuticals India Ltd is headquartered at E-11 Industrial Areapanipat, Haryana, Haryana, 132103.

When was Laborate Pharmaceuticals India Ltd incorporated?

Laborate Pharmaceuticals India Ltd was incorporated on 01 March 1990.

Who are the current directors of Laborate Pharmaceuticals India Ltd?

The current directors of Laborate Pharmaceuticals India Ltd are

What is the primary industry of Laborate Pharmaceuticals India Ltd?

The primary industry of Laborate Pharmaceuticals India Ltd is Manufacturing.

Is Laborate Pharmaceuticals India Ltd a listed company?

Laborate Pharmaceuticals India Ltd is unlisted.

What is the capital structure of Laborate Pharmaceuticals India Ltd?

The authorized capital of Laborate Pharmaceuticals India Ltd is ₹5.00 Cr, and the paid-up capital is ₹2.63 Cr.

What is the compliance status of Laborate Pharmaceuticals India Ltd?

The compliance status of Laborate Pharmaceuticals India Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available